Examining Breaks and Resistance in Medication Adherence Among Adolescents With ADHD as Associated With School Outcomes

Abstract

Objective: Pharmacological interventions combined with behavioral treatment have been associated with better outcomes for children with ADHD. Yet, as children age into adolescence and gain autonomy, they may choose not to adhere to taking a prescribed medication. The purpose of the current study was to examine school outcomes among adolescents with ADHD who take medication breaks versus resisting medication with respect to grades and school behaviors. Method: We statistically controlled for a variety of variables such as the child’s age, sex, the presence of side effects, and parent’s relationship with child. Approximately half of the sample of adolescents with ADHD exhibited some form of medication nonadherence. Results: The results of the current study suggest that more positive school outcomes in terms of behaviors and grades are associated with adolescents taking breaks from their ADHD medication rather than resisting their medication. Conclusion: This result would indicate that not all forms of medication nonadherence have the same association with school outcomes in terms of grades and behaviors.

Keywords

adolescence medication adherence schools

Get full access to this article

View all access options for this article.

References

Adler

L. D.

Nierenberg

A. A.

(2010). Review of medication adherence in children and adults with ADHD. Postgraduate Medicine, 122, 184-191.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington: Author.

Barnard-Brak

Schmidt

Sulak

(2013). ADHD medication vacations and parent–child interactions by gender. Journal of Attention Disorders, 17, 506-509.

Barnard-Brak

Schmidt

Wei

Parker

S. L.

Attai

S. L.

(2013). Parental perceptions of academic performance and attainment of children diagnosed with attention deficit hyperactivity disorder. The Journal of Nervous and Mental Disease, 201, 598-601.

Barner

J. C.

Khoza

Oladapo

(2011). ADHD medication use, adherence, persistence and cost among Texas Medicaid children. Current Medical Research & Opinion, 27(Suppl. 2), 13-22.

Bhang

S. Y.

Kwack

Y. S.

Joung

Y. S.

Lee

S. I.

Kim

Sohn

S. H.

. . . Choi

H. Y.

(2017). Factors that affect the adherence to ADHD medications during a treatment continuation period in children and adolescents: A nationwide retrospective cohort study using Korean Health Insurance Data from 2007 to 2011. Psychiatry Investigation, 14, 158-165.

Bloom

Cohen

R. A.

Freeman

(2012). Summary health statistics for US children; National health interview survey, 2011.

Bolt

Schermer

(2009). Psychopharmaceutical enhancers: Enhancing identity? Neuroethics, 2, 103-111.

Bussing

Gary

F. A.

(2001). Practice guidelines and parental ADHD treatment evaluations: friends or foes?. Harvard Review of Psychiatry, 9, 223-233.

10.

Centers for Disease Control and Prevention. (2015). National Survey of the Diagnosis and Treatment of ADHD and Tourette Syndrome. Retrieved from http://www.cdc.gov/nchs/slaits/ns_data.htm

11.

Chacko

A. H.

Newcorn

Feirsen

N. Z.

Uderman

(2010). Improving medication adherence in chronic pediatric health conditions: A focus on ADHD in youth. Current Pharmaceutical Design, 16, 2416-2423.

12.

Charach

Gajaria

(2008). Improving psychostimulant adherence in children with ADHD. Expert Review of Neurotherapeutics, 8, 1563-1571.

13.

Charach

Skyba

Cook

Antle

B. J.

(2006). Using stimulant medication for children with ADHD: What do parents say? A brief report. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 15, 75-83.

14.

Charach

Yeung

Volpe

Goodale

(2014). Exploring stimulant treatment in ADHD: narratives of young adolescents and their parents. BMC psychiatry, 14, 110.

15.

Coletti

D. J.

Pappadopulos

Katsiotas

N. J.

Berest

Jensen

P. S.

Kafantaris

(2012). Parent perspectives on the decision to initiate medication treatment of attention-deficit/hyperactivity disorder. Journal of child and adolescent psychopharmacology, 22, 226-237.

16.

DuPaul

G. J.

(1991). Parent and teacher ratings of ADHD symptoms: Psychometric properties in a community-based sample. Journal of Clinical Child & Adolescent Psychology, 20, 245-253.

17.

DuPaul

G. J.

Stoner

(2014). ADHD in the schools: Assessment and intervention strategies. Guilford Publications.

18.

Enders

C. K.

Bandalos

D. L.

(2001). The relative performance of full information maximum likelihood estimation for missing data in structural equation models. Structural Equation Modeling, 8, 430-457.

19.

Farah

M. J.

Haimm

Sankoorikal

Chatterjee

(2009). When we enhance cognition with Adderall, do we sacrifice creativity? A preliminary study. Psychopharmacology, 202, 541-547.

20.

Frank

Ozon

Nair

Othee

(2015). Examining why patients with attention-deficit/hyperactivity disorder lack adherence to medication over the long term: A review and analysis. The Journal of Clinical Psychiatry, 76, e1459-68.

21.

Gajria

Sikirica

Greven

Zhong

Qin

Xie

(2014). Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder—A systematic literature review. Neuropsychiatric Disease and Treatment, 10, 1543-1569.

22.

Gau

S. S.

Shen

H. Y.

Chou

M. C.

Tang

C. S.

Chiu

Y. N.

Gau

C. S.

(2006). Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. Journal of Child & Adolescent Psychopharmacology, 16, 286-297.

23.

Gould

O. N.

Doucette

(2018). Self-management of adherence to prescribed stimulants in college students with ADD/ADHD. Journal of Attention Disorders, 22, 349-355.

24.

Hahs-Vaughn

D. L.

(2005). A primer for using and understanding weights with national datasets. The Journal of Experimental Education, 73, 221-248.

25.

Hahs-Vaughn

D. L.

(2006). Analysis of data from complex samples. International Journal of Research & Method in Education, 29, 165-183.

26.

Howland

R. H.

Rush

A. J.

Wisniewski

S. R.

Trivedi

M. H.

Warden

Fava

Berman

S. R.

(2009). Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug & Alcohol Dependence, 99, 248-260.

27.

Ibrahim

Donyai

(2015). Drug holidays from ADHD medication: International experience over the past four decades. Journal of Attention Disorders, 19, 551-568.

28.

Jensen

P. S.

Hinshaw

S. P.

Swanson

J. M.

Greenhill

L. L.

Conners

C. K.

Arnold

L. E.

. . . March

J. S

. (2001). Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers. Journal of Developmental & Behavioral Pediatrics, 22, 60-73.

29.

Kooij

J. J.

Marije Boonstra

Swinkels

S. H. N.

Bekker

E. M.

de Noord

Buitelaar

J. K.

(2008). Reliability, validity, and utility of instruments for self-report and informant report concerning symptoms of ADHD in adult patients. Journal of Attention Disorders, 11, 445-458.

30.

Kosse

R. C.

Bouvy

M. L.

Philbert

De Vries

T. W.

Koster

E. S.

(2017). Attention-Deficit/Hyperactivity Disorder Medication Use in Adolescents: The Patient’s Perspective. Journal of Adolescent Health, 61, 619-625.

31.

Lahey

B. B.

Pelham

W. E.

Chronis

Massetti

Kipp

Ehrhardt

Lee

S. S.

(2006). Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children. Journal of Child Psychology and Psychiatry, 47, 472-479.

32.

Loe

I. M.

Feldman

H. M.

(2007). Academic and educational outcomes of children with ADHD. Journal of Pediatric Psychology, 32, 643-654.

33.

Molina

B. S.

Hinshaw

S. P.

Swanson

J. M.

Arnold

L. E.

Vitiello

Jensen

P. S.

. . . Elliott

G. R.

(2009). The MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child & Adolescent Psychiatry, 48, 484-500.

34.

Muthén

L. K.

Muthén

B. O.

(2013). Mplus user’s guide. Los Angeles, CA: Author.

35.

Pappadopulos

Jensen

P. S.

Chait

A. R.

Arnold

L. E.

Swanson

J. M.

Greenhill

L. L.

. . . Cooper

(2009). Medication adherence in the MTA: Saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. Journal of the American Academy of Child & Adolescent Psychiatry, 48, 501-510.

36.

Polanczyk

G. V.

Willcutt

E. G.

Salum

G. A.

Kieling

Rohde

L. A.

(2014). ADHD prevalence estimates across three decades: An updated systematic review and meta-regression analysis. International Journal of Epidemiology, 43, 434-442.

37.

Prasad

Brogan

Mulvaney

Grainge

Stanton

Sayal

(2013). How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis. European Child & Adolescent Psychiatry, 22, 203-216.

38.

Rathus

S. A.

(2015). Hdev. Cengage Learning.

39.

Safren

S. A.

Duran

Yovel

Perlman

C. A.

Sprich

(2007). Medication adherence in psychopharmacologically treated adults with ADHD. Journal of Attention Disorders, 10, 257-260.

40.

Sanchez

R. J.

Crismon

M. L.

Barner

J. C.

Bettinger

Wilson

J. P.

(2005). Assessment of adherence measures with different stimulants among children and adolescents. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 25, 909-917.

41.

Sciutto

M. J.

Nolfi

C. J.

Bluhm

(2004). Effects of child gender and symptom type on referrals for ADHD by elementary school teachers. Journal of Emotional and Behavioral Disorders, 12, 247-253.

42.

Sibley

M. H.

Altszuler

A. R.

Ross

J. M.

Sanchez

Pelham

W. E.

Gnagy

E. M.

(2014). A parent-teen collaborative treatment model for academically impaired high school students with ADHD. Cognitive and Behavioral Practice, 21, 32-42.

43.

Sibley

M. H.

Kuriyan

A. B.

Evans

S. W.

Waxmonsky

J. G.

Smith

B. H.

(2014). Pharmacological and psychosocial treatments for adolescents with ADHD: An updated systematic review of the literature. Clinical Psychology Review, 34, 218-232.

44.

Singh

(2013). Not robots: Children’s perspectives on authenticity, moral agency and stimulant drug treatments. Journal of Medical Ethics, 39, 359-366.

45.

Singh

(2005). Collaborative networks as determinants of knowledge diffusion patterns. Management science, 51(5), 756-770.

46.

Sobanski

Retz

Fischer

Ose

Alm

Hennig

Rösler

(2014). Treatment adherence and persistence in adult ADHD: Results from a twenty-four week controlled clinical trial with extended release methylphenidate. European Psychiatry, 29, 324-330.

47.

Thiruchelvam

Charach

Schachar

R. J.

(2001). Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 40(8), 922-928.

48.

Vrecko

(2013). Just how cognitive is “cognitive enhancement”? On the significance of emotions in university students’ experiences with study drugs. AJOB Neuroscience, 4(1), 4-12.

49.

Wehmeier

P. M.

Dittmann

R. W.

Banaschewski

(2015). Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: Results from the COMPLY observational study. ADHD Attention Deficit and Hyperactivity Disorders, 7, 165-174.

50.

Wong

I. C.

Asherson

Bilbow

Clifford

Coghill

DeSoysa

Potts

(2009). Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)–a pharmacoepidemiological and qualitative study. Health Technology Assessment, 13(50), 1-120.